Open | 1.34 |
Previous Close | 1.39 |
Day Range | 1.34 - 1.41 |
52-Week Range | 1.36 - 16.26 |
All-Time High | 87.19 |
Avg. Volume (50-day) | 1,685,577.9 |
EPS (TTM) | -2.33 |
Next Earnings Date | 2025-05-07 (AMC) |
Last Earnings Date | 2025-03-26 |
Forward Annual Dividend (Yield) | - |
Trailing Annual Dividend (Yield) | - |
Options | Yes |
P/E Ratio | -0.60 |
PEG Ratio | - |
Price to Book | 0.29 |
Price to Cash Flow | - |
Price to Free Cash Flow | - |
Total Sales (TTM) | 67.42 M |
Revenue per Share (TTM) | 0.95 |
Shares Outstanding | 71.811 M |
Share Float (%) | 54.00 M |
% Held by Institutions | 86.97 |
Dividends Per Share (TTM) | - |
Ex-Dividend Date | - |
+/- EMA(20) | 1.78 (-23.03%) |
+/- SMA(50) | 1.99 (-31.16%) |
+/- SMA(200) | 3.14 (-56.37%) |
5-Day Perf. | -22.16% |
1-Month Perf. | -33.82% |
3-Month Perf. | -54.33% |
6-Month Perf. | -59.1% |
YTD Perf. | -54.79% |
1-Year Perf. | -90.51% |
RSI(14) | 30.44 |
ATR(14) | 0.18 |
ADX(14) | 15.5 |
Beta (5Y) | 1.43 |
As a StockCharts Member, you can review earnings results and analyze revenue and earnings growth over time. Bring a balance of technicals and fundamentals to your approach when you join today!
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. The company was founded by Kevin D. Bunker and Cam Gallagher on December 23, 2014 and is headquartered in San Diego, CA.
ZNTL has triggered the following predefined scans:
P&F Double Bottom Breakdown |
P&F Descending Triple Bottom Breakdown |
New 52-week Lows |
Hollow Red Candles |
As a StockCharts Member, you can create your own unique alerts with the technical criteria that matters most to you. Stay ahead of important moves and never miss a thing in the markets.
As a StockCharts Member, you can save the charts you're watching to your own account with ChartLists. Accessible from any device, you can organize, review and analyze your charts on-the-go, anytime, anywhere.